|
Role of NFxB/HIF2a axis in renal cell carcinoma progression
|
4K08CA178168-04
|
$175,163
|
$175,163
|
ABEL, E
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-03S1
|
$3,025,319
|
$181,519
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Solid Malignancy Integrated Translational Science Center
|
5U10CA180884-03
|
$400,000
|
$80,000
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
5U10CA180886-03
|
$21,084,883
|
$1,265,093
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center
|
3U10CA180791-02S1
|
$400,000
|
$12,000
|
AGHAJANIAN, CAROL
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center
|
5U10CA180791-03
|
$737,200
|
$22,116
|
AGHAJANIAN, CAROL
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
ATBC Study
|
ZIA CP010195-03031
|
$1,193,520
|
$59,676
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
Naional Cancer Institute, Naitonal Clinical Trials Network U10 Lead Academic Site
|
5U10CA180790-03
|
$1,295,865
|
$38,876
|
ALBERTS, STEVEN
|
MAYO CLINIC ROCHESTER
|
|
NCTN Deep South Research Consortium
|
5U10CA180855-03
|
$497,800
|
$12,445
|
ALVAREZ, RONALD
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$791,464
|
$39,573
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Hutchinson Center as Lead Academic Participating Site (U10)
|
5U10CA180828-03
|
$541,578
|
$27,079
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Childhood Cancer Survivor Study
|
4U24CA055727-22
|
$4,172,004
|
$417,200
|
ARMSTRONG, GREGORY
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Interferon Activated Necroptosis as a New Therapeutic Avenue for Kidney Cancer
|
5R01CA168621-03
|
$370,388
|
$370,388
|
BALACHANDRAN, SIDDHARTH
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead
|
ZIA BC 011232
|
$485,441
|
$48,544
|
Barchi, Joseph
|
CCR (NCI)
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,014,935
|
$50,747
|
Barr, Frederic
|
CCR (NCI)
|
|
Cancer Center Support Grant
|
3P30CA006516-51S1
|
$122,500
|
$1,225
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-51S2
|
$37,500
|
$375
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-51S3
|
$125,000
|
$1,250
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-51S4
|
$200,000
|
$2,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-51S5
|
$60,000
|
$600
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-51S6
|
$199,953
|
$2,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-51S7
|
$500,000
|
$5,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-51S8
|
$750,000
|
$7,500
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
4P30CA006516-51
|
$11,151,311
|
$111,513
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Vanderbilt Network Lead Academic Participating Site for the NCTN
|
5U10CA180847-03
|
$9,808
|
$490
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY
|
|
Vanderbilt Network Lead Academic Participating Site for the NCTN
|
6U10CA180847-04
|
$410,211
|
$20,511
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-03S1
|
$1,595,651
|
$31,913
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-03S2
|
$550,000
|
$11,000
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-03S3
|
$750,000
|
$15,000
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
5U10CA180821-03
|
$9,068,022
|
$181,360
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
2016 AUA Urologic Oncology Research Symposium: ""Forging New Paths in Research to Advance Urologic Oncology
|
1U13CA206383-01
|
$10,000
|
$3,300
|
BEST, CAROLYN
|
AMERICAN UROLOGICAL ASSOCIATION
|
|
Development of Natural Product Leads as Anticancer Therapeutics
|
ZIA BC 011470
|
$280,052
|
$70,013
|
Beutler, John
|
CCR (NCI)
|
|
Combating Resistance to Antiangiogenic Therapy in Renal Cell Carcinoma
|
5R01CA196996-02
|
$398,025
|
$398,025
|
BHATT, RUPAL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Medical Oncology Fellowship Program
|
ZIE BC 010843
|
$4,305,516
|
$430,552
|
Bilusic, Marijo
|
CCR (NCI)
|
|
SWOG Network Group Operations Center of the NCTN
|
3U10CA180888-03S1
|
$308,895
|
$6,178
|
BLANKE, CHARLES
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
SWOG Network Group Operations Center of the NCTN
|
5U10CA180888-03
|
$5,204,873
|
$104,097
|
BLANKE, CHARLES
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Hypoxia and Tyrosine Kinase Signaling Integration in Urologic Cancers
|
ZIA BC 011095
|
$200,076
|
$200,076
|
Bottaro, Donald
|
CCR (NCI)
|
|
Oncogenic Met Signaling in Urologic Malignancies
|
ZIA BC 011124
|
$371,569
|
$92,892
|
Bottaro, Donald
|
CCR (NCI)
|
|
1/2 Addressing Rural Cancer Health Disparities: An SCC-SIUSM Partnership
|
5P20CA192987-02
|
$215,236
|
$215,236
|
BRARD, LAURENT
|
SOUTHERN ILLINOIS UNIVERSITY SCH OF MED
|
|
NCI NCTN-Network Lead Academic Site at UPCI
|
5U10CA180844-03
|
$853,523
|
$21,338
|
BRUFSKY, ADAM
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
The University of Texas Southwestern Medical Center SPORE in Kidney Cancer
|
1P50CA196516-01A1
|
$2,162,000
|
$2,162,000
|
BRUGAROLAS, JAMES
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Evaluation of the BAP1 tumor suppressor gene in renal cell carcinoma
|
5R01CA175754-03
|
$329,925
|
$329,925
|
BRUGAROLAS, JAMES
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Molecular biology of human polyomaviruses
|
ZIA BC 011090
|
$364,996
|
$36,500
|
Buck, Christopher
|
CCR (NCI)
|
|
BKV and JCV vaccine development
|
ZIA BC 011460
|
$364,996
|
$255,497
|
Buck, Christopher
|
CCR (NCI)
|
|
NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care
|
5U10CA180867-03
|
$1,106,869
|
$41,508
|
BURSTEIN, HAROLD
|
DANA-FARBER CANCER INST
|
|
Families at high risk of cancer
|
ZIA CP004410-08285
|
$198,789
|
$9,939
|
Caporaso, Neil
|
DCEG (NCI)
|
|
NCTN Lead Academic Participating Sites Application
|
5U10CA180838-03
|
$474,318
|
$11,858
|
CAREY, LISA
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Proteo-genomic Discovery, Prioritization and Verification of Cancer Biomarkers
|
3U24CA160034-05S1
|
$825,543
|
$206,386
|
CARR, STEVEN
|
BROAD INSTITUTE, INC.
|
|
Urologic Oncology Research Training Grant
|
5T32CA082088-17
|
$275,994
|
$41,399
|
CARVER, BRETT
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Mechanisms of Action of a TCR-like mAb Directed Against WT1
|
5F31CA189305-02
|
$27,576
|
$27,576
|
CASEY, EMILY
|
SLOAN-KETTERING INST CAN RESEARCH
|
Total relevant funding to Kidney Disease for this search: $43,443,841
|